Hyperglycemia and elevated C-reactive protein are independent predictors of hospital mortality in hospitalized COVID-19 patients in South-Kivu, eastern Democratic Republic of the Congo: A cross-sectional study.

COVID‐19 South‐Kivu hospital mortality hyperglycemia inflammation prognosis

Journal

Health science reports
ISSN: 2398-8835
Titre abrégé: Health Sci Rep
Pays: United States
ID NLM: 101728855

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 10 08 2023
revised: 29 10 2023
accepted: 14 12 2023
medline: 12 1 2024
pubmed: 12 1 2024
entrez: 12 1 2024
Statut: epublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic was a priority public health problem because of its high mortality rate. This study mainly aimed to determine factors associated with a poor outcome in COVID-19 hospitalized patients in South-Kivu, an eastern province of the Democratic Republic of the Congo (DRC). This observational study retrospectively evaluated medical records of patients consecutively admitted for probable or confirmed COVID-19 between May 01 and July 31, 2020 at the Hôpital Provincial Général de Référence de Bukavu (HPGRB), a tertiary hospital located in South-Kivu. A binary logistic regression model was performed to determine the predictors of mortality. A total of 157 hospitalized COVID-19 patients aged 57.7 (13.2) years were included in this study. Male gender (69.4%), older age (52.9%), medical history of diabetes (38.2%), and arterial hypertension (35.1%) were the most frequent risk factors. Most patients presented with fever (73.3%), cough (72.6%), and dyspnea (66.2%). Overall, 45.1% of patients died. Intrahospital mortality was significantly associated with advanced age [odds ratio, OR (95% confidence interval, CI) = 2.34 (1.06-5.38)], hypoxemia [OR (95% CI) = 4.67 (2.02-10.77)], hyperglycemia [OR (95% CI) = 2.14 (1.06-4.31)], kidney failure [OR (95% CI) = 2.82 (1.4-5.68)], hyperleukocytosis [OR (95% CI) = 3.33 (1.67-6.66)], and higher C-reactive protein (CRP) levels [OR (95% CI) = 3.93 (1.93-8.01)]. After adjustment for various covariates, only higher CRP levels [OR (95% CI) = 3.23 (1.23-8.5)] and hyperglycemia [OR (95% CI) = 2.5 (1.02-6.11)] at admission were independently associated with mortality. Hyperglycemia and marked inflammatory syndrome were the major predictors of poor outcomes in patients hospitalized for COVID-19 in South-Kivu. These two factors should be quantified at hospital admission to establish the patient's prognosis.

Sections du résumé

Background and Aim UNASSIGNED
The coronavirus disease 2019 (COVID-19) pandemic was a priority public health problem because of its high mortality rate. This study mainly aimed to determine factors associated with a poor outcome in COVID-19 hospitalized patients in South-Kivu, an eastern province of the Democratic Republic of the Congo (DRC).
Methods UNASSIGNED
This observational study retrospectively evaluated medical records of patients consecutively admitted for probable or confirmed COVID-19 between May 01 and July 31, 2020 at the Hôpital Provincial Général de Référence de Bukavu (HPGRB), a tertiary hospital located in South-Kivu. A binary logistic regression model was performed to determine the predictors of mortality.
Results UNASSIGNED
A total of 157 hospitalized COVID-19 patients aged 57.7 (13.2) years were included in this study. Male gender (69.4%), older age (52.9%), medical history of diabetes (38.2%), and arterial hypertension (35.1%) were the most frequent risk factors. Most patients presented with fever (73.3%), cough (72.6%), and dyspnea (66.2%). Overall, 45.1% of patients died. Intrahospital mortality was significantly associated with advanced age [odds ratio, OR (95% confidence interval, CI) = 2.34 (1.06-5.38)], hypoxemia [OR (95% CI) = 4.67 (2.02-10.77)], hyperglycemia [OR (95% CI) = 2.14 (1.06-4.31)], kidney failure [OR (95% CI) = 2.82 (1.4-5.68)], hyperleukocytosis [OR (95% CI) = 3.33 (1.67-6.66)], and higher C-reactive protein (CRP) levels [OR (95% CI) = 3.93 (1.93-8.01)]. After adjustment for various covariates, only higher CRP levels [OR (95% CI) = 3.23 (1.23-8.5)] and hyperglycemia [OR (95% CI) = 2.5 (1.02-6.11)] at admission were independently associated with mortality.
Conclusion UNASSIGNED
Hyperglycemia and marked inflammatory syndrome were the major predictors of poor outcomes in patients hospitalized for COVID-19 in South-Kivu. These two factors should be quantified at hospital admission to establish the patient's prognosis.

Identifiants

pubmed: 38213779
doi: 10.1002/hsr2.1803
pii: HSR21803
pmc: PMC10782469
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e1803

Informations de copyright

© 2024 The Authors. Health Science Reports published by Wiley Periodicals LLC.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Christian Tshongo (C)

Faculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.

Marius Baguma (M)

Faculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
Center for Tropical Diseases and Global Health (CTDGH) Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.

Guy-Quesney Mateso (GQ)

Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.

Samuel Lwamushi Makali (SL)

Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
École Régionale de Santé Publique Université Catholique de Bukavu Bukavu Democratic Republic of the Congo.

Aline Bedha (A)

Faculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.

Pacifique Mwene-Batu (P)

Faculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
École Régionale de Santé Publique Université Catholique de Bukavu Bukavu Democratic Republic of the Congo.

Martine Mihigo (M)

Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.

Fabrice Nzabara (F)

Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.

Cordule Balola (C)

Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.

Pierre Kabuya (P)

Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.

Achille Bapolisi (A)

Faculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.

Mannix I Masimango (MI)

Faculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.

Esto Bahizire (E)

Faculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.

Ghislain Maheshe-Balemba (G)

Faculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
École Régionale de Santé Publique Université Catholique de Bukavu Bukavu Democratic Republic of the Congo.

Tony A Shindano (TA)

Faculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
Center for Tropical Diseases and Global Health (CTDGH) Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.

Cikomola Cirhuza (C)

Faculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Department of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
Center for Tropical Diseases and Global Health (CTDGH) Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.

Classifications MeSH